Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,887,048
+$326,775 QoQ
Shares Held
7,499
+4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#2,012
of 4,153 holders
Holding Since
Jun 2022
15 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global Assets Advisory, LLC holds $15,531,506 across 6 Drug Manufacturers - General names. ABBV ranks #3 (12.1% of the industry book) .
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,887,048 | 7,499 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,560,273 | 7,174 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,618,623 | 7,084 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,590,448 | 6,869 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,161,424 | 6,257 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,416,184 | 11,532 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $810,845 | 4,563 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $999,051 | 5,059 | Shares | Sole | 2024-10-22 | |
| 2024-03-31 | $4,832 | 873,418 | Shares | Sole | 2024-04-12 | |
| 2023-09-30 | $968,591 | 6,498 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $1,173,902 | 8,713 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,035,744 | 6,499 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $848,614 | 5,251 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $758,420 | 5,651 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $628,721 | 4,105 | Shares | Sole | 2022-08-17 | |
| No filing history on record for this holder in this stock. | ||||||